Location: Home
  • search
  • go
  • Relate News
  • 6/1/2010Pharma China co-founds healthcare communications service in China
  • 6/1/2010Lizhu and Joincare forms JV for monoclonal antibody drugs
  • 6/1/2010New steroid API manufacturing facility begins operation in Shaanxi
  • 5/31/2010SIPI: China's hospital drug market growth slows in 2009
  • 5/31/2010Kelun Pharma's IPO may be suspended again
  • 5/28/2010MOH outlines cost containment measures for drug expenditures
  • 5/28/2010MSD China: pricing flexibilities for expanded market?
  • 5/28/2010NH: Global OTC drug market grew 4.6% despite economic woes
  • 5/28/2010NH: Chinese OTC dermatological sales up 9% in 2009
  • 5/28/2010Pfizer sells Chinese swine-vaccine business to Harbin Pharma
  • 5/28/2010HUYA Bioscience enters strategic partnership with TCM university
  • 5/28/2010Is the NDRC Bluffing or Signaling A New Round of Price Cuts?
  • 5/28/2010IMS: China is home to an especially strong oncology market
  • 5/27/2010Shanxi Zhendong Pharma acquires major pharmaceutical distributor
  • 5/27/2010Chiltern announces new offices and expansion plans in Asia Pacific
  • 5/26/2010The Increased Use of Nanotechnology in China's Biotech Industry
  • 5/26/2010Hemispherx to conduct clinical trials of its antiviral in China
  • 5/26/2010Electronic regulation of essential drugs to initiate from 2011
  • 5/26/2010Zhejiang reports achievements of the EDS implementation
  • 5/26/2010Hubei province adds 118 non-essential drugs on top of the NEDL
  • 5/26/2010CRG completes plan for reorganization of BPG
  • 5/26/2010First brain glioma treatment center in south China established with su...
  • 5/25/2010Astellas seeks to double its China revenues by 2015
  • 5/25/2010Taiwan eyes cooperation with mainland in biotech development
  • 5/25/2010NDRC will adopt four new measures to strengthen control of drug prices...
  • 5/25/2010Upcoming Event: BioProcess International China 2010
  • 5/24/2010Bilingual medical executive with extensive Asian expertise seeks relev...
  • 5/24/2010Drug Price Reform Looms as SFDA Faces More Challenges
  • 5/24/2010Kelun to sell 25% stake for CNY 5 billion at SHSE IPO
  • 5/24/2010NDRC reports healthcare reform progress with CNY 390B government inves...
  • Page:616/775 Total number of articles:23222: [First][<<] [614] [615] [616] [617] [618] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group